0001140361-21-033143.txt : 20210930
0001140361-21-033143.hdr.sgml : 20210930
20210930173546
ACCESSION NUMBER: 0001140361-21-033143
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210928
FILED AS OF DATE: 20210930
DATE AS OF CHANGE: 20210930
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sherpa Ventures Fund, LP
CENTRAL INDEX KEY: 0001580437
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40824
FILM NUMBER: 211296012
BUSINESS ADDRESS:
STREET 1: 555 MISSION STREET, SUITE 1850
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105-0937
BUSINESS PHONE: (415) 655 9887
MAIL ADDRESS:
STREET 1: 555 MISSION STREET, SUITE 1850
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105-0937
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sherpa Ventures Fund GP, LLC
CENTRAL INDEX KEY: 0001580438
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40824
FILM NUMBER: 211296010
BUSINESS ADDRESS:
STREET 1: 555 MISSION STREET, SUITE 1850
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105-0937
BUSINESS PHONE: (415) 655 9887
MAIL ADDRESS:
STREET 1: 555 MISSION STREET, SUITE 1850
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105-0937
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SherpaVentures Fund II GP, LLC
CENTRAL INDEX KEY: 0001640277
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40824
FILM NUMBER: 211296009
BUSINESS ADDRESS:
STREET 1: 800 MARKET STREET, SUITE 800
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94102
BUSINESS PHONE: 415 805 8500
MAIL ADDRESS:
STREET 1: 800 MARKET STREET, SUITE 800
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SherpaVentures Fund II, LP
CENTRAL INDEX KEY: 0001640276
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40824
FILM NUMBER: 211296011
BUSINESS ADDRESS:
STREET 1: 800 MARKET STREET, SUITE 800
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94102
BUSINESS PHONE: 415 805 8500
MAIL ADDRESS:
STREET 1: 800 MARKET STREET, SUITE 800
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94102
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cue Health Inc.
CENTRAL INDEX KEY: 0001628945
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4980 CARROLL CANYON ROAD
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 412-8151
MAIL ADDRESS:
STREET 1: 4980 CARROLL CANYON ROAD
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: Cue Inc.
DATE OF NAME CHANGE: 20141223
FORMER COMPANY:
FORMER CONFORMED NAME: Cue, Inc.
DATE OF NAME CHANGE: 20141222
4
1
form4.xml
FORM 4
X0306
4
2021-09-28
0001628945
Cue Health Inc.
HLTH
0001580437
Sherpa Ventures Fund, LP
800 MARKET STREET, 8TH FLOOR
SAN FRANCISCO
CA
94102
true
0001640276
SherpaVentures Fund II, LP
800 MARKET STREET, 8TH FLOOR
SAN FRANCISCO
CA
94102
true
0001580438
Sherpa Ventures Fund GP, LLC
800 MARKET STREET, 8TH FLOOR
SAN FRANCISCO
CA
94102
true
0001640277
SherpaVentures Fund II GP, LLC
800 MARKET STREET, 8TH FLOOR
SAN FRANCISCO
CA
94102
true
Common Stock
2021-09-28
4
C
0
9619451
A
9748805
I
See footnote.
Common Stock
2021-09-28
4
C
0
4926417
A
5120448
I
See footnote.
Common Stock
2021-09-28
4
J
0
371293
12.8
A
5491741
I
See footnote.
Series A Preferred Stock
2021-09-28
4
C
0
5450898
0
D
Common Stock
5450898
0
I
See footnote.
Series B Preferred Stock
2021-09-28
4
C
0
3076224
0
D
Common Stock
3076224
0
I
See footnote.
Series C-1 Preferred Stock
2021-09-28
4
C
0
1092329
0
D
Common Stock
1092329
0
I
See footnote.
Series B Preferred Stock
2021-09-28
4
C
0
3834088
0
D
Common Stock
3834088
0
I
See footnote.
Series C-1 Preferred Stock
2021-09-28
4
C
0
1092329
0
D
Common Stock
1092329
0
I
See footnote.
On September 28, 2021, the Series A Preferred Stock automatically converted into Common Stock on a one-to-one basis without payment of further consideration upon the closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
On September 28, 2021, the Series B Preferred Stock automatically converted into Common Stock on a one-to-one basis without payment of further consideration upon the closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
On September 28, 2021, the Series C-1 Preferred Stock automatically converted into Common Stock on a one-to-one basis without payment of further consideration upon the closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
The shares are held directly by Sherpa Ventures Fund, LP ("ACME I"). Sherpa Ventures Fund GP, LLC ("ACME GP I") is the general partner of ACME I. Each of the reporting persons disclaims beneficial ownership of the shares reported herein except to the extent of its respective pecuniary interest therein.
The shares are held directly by Sherpa Ventures Fund II, LP ("ACME II"). Sherpa Ventures Fund II GP, LLC ("ACME GP II") is the general partner of ACME II. Each of the reporting persons disclaims beneficial ownership of the shares reported herein except to the extent of its respective pecuniary interest therein.
On September 28, 2021, outstanding principal and accrued interest underlying a convertible note automatically converted into Common Stock upon the closing of the initial public offering of the Issuer's common stock at a conversion price equal to 80% of the initial public offering price per share.
SHERPA VENTURES FUND, LP
By: Sherpa Ventures Fund GP, LLC, its general partner
By: /s/ Scott Stanford, Manager
2021-09-30
SHERPA VENTURES FUND II, LP
By: Sherpa Ventures Fund II GP, LLC, its general partner
By: /s/ Scott Stanford, Manager
2021-09-30
SHERPA VENTURES FUND GP, LLC
By: /s/ Scott Stanford, Manager
2021-09-30
SHERPA VENTURES FUND II GP, LLC
By: /s/ Scott Stanford, Manager
2021-09-30